{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-020811","form_type":"8-K/A","ticker":"REFI","cik":"0001867949","company_name":"Chicago Atlantic Real Estate Finance, Inc.","filed_at":"2022-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.947169+00:00","generated_at":"2026-06-26T06:18:09.177654+00:00","sec_items":["9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Chicago Atlantic REFI amends 8-K; determines no borrower financials required for FarmaceuticalRX loan","bullets":["Amendment to February 8, 2022 8-K regarding $ loan commitment to FarmaceuticalRX LLC.","Re-evaluated significance using FY 2021 financial statements filed April 14, 2022.","Determined audited financials of Borrowers under Rule 3-14 are not required.","No pro forma financial information required either.","Filing is procedural; no change in loan terms or business operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-020811","json":"https://secwatch.observer/filing/0001213900-22-020811.json","markdown":"https://secwatch.observer/filing/0001213900-22-020811.md","text":"https://secwatch.observer/filing/0001213900-22-020811.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867949/000121390022020811/0001213900-22-020811-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867949/000121390022020811/ea158672-8k_chiatl.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T06:18:09.177654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}